Central Retinal Vein Occlusion
Showing 1 - 25 of 46
Functional Optical Coherence Tomography for Ocular Imaging
Completed
- Glaucoma
- +4 more
- Optical Coherence Tomography
-
Irvine, CaliforniaBeckman Laser Institute, University of California,Irvine
Oct 19, 2022
Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)
Completed
- Glaucoma
- +12 more
- Free Eye Screenings
- +2 more
-
Philadelphia, PennsylvaniaWills Eye Glaucoma Service
Aug 19, 2022
Central Retinal Vein Occlusion Trial in Paris, Strasbourg, Écully (Ophthalmologic exam at inclusion and 12 months after CRVO,
Recruiting
- Central Retinal Vein Occlusion
- Ophthalmologic exam at inclusion and 12 months after CRVO
- Treatment standardization with aflibercept
-
Paris, France
- +2 more
Oct 19, 2021
Central Retinal Vein Occlusion Trial in United States (aflibercept, bevacizumab)
Completed
- Central Retinal Vein Occlusion
-
Phoenix, Arizona
- +71 more
Jun 11, 2021
Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)
Completed
- Retinal Vein Occlusion
- +3 more
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
May 10, 2021
Central Retinal Vein Occlusion Trial in TianJing (601 1.25mg, Ranibizuman 0.5 mg)
Not yet recruiting
- Central Retinal Vein Occlusion
- 601 1.25mg
- Ranibizuman 0.5 mg
-
TianJing, TianJing, ChinaTianJing Medical University Eye Hospital
Dec 8, 2020
Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)
Completed
- Central Retinal Vein Occlusion
-
Stockholm, SwedenSt Eriks Eye Hospital
Dec 3, 2020
Central Retinal Vein Occlusion Trial in Shenyang (Bevacizumab Ophthalmic and Intravitreal Dexamethasone., Bevacizumab
Unknown status
- Central Retinal Vein Occlusion
- Bevacizumab Ophthalmic and Intravitreal Dexamethasone.
- Bevacizumab Ophthalmic.
-
Shenyang, Liaoning, ChinaHe Eye Specialist Hospital
Oct 20, 2020
Central Retinal Vein Occlusion Trial in Worldwide (Aflibercept (Eylea, BAY86-5321))
Completed
- Central Retinal Vein Occlusion
- Aflibercept (Eylea, BAY86-5321)
-
Albury, New South Wales, Australia
- +41 more
Jun 19, 2020
Central Retinal Vein Occlusion Trial in Leuven (Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse)
Completed
- Central Retinal Vein Occlusion
- Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse) infusion up to 1mg.
- Intravenous Infusion
-
Leuven, Vlaams Brabant, BelgiumUZ Leuven
May 6, 2020
Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion Trial in Palo Alto (nicotinic acid)
Terminated
- Central Retinal Vein Occlusion
- Branch Retinal Vein Occlusion
- nicotinic acid
-
Palo Alto, CaliforniaPalo Alto Medical Foundation Department of Ophthalmology
Oct 21, 2019
Central Retinal Vein Occlusion Trial in New York (Tissue Plasminogen Activator)
Completed
- Central Retinal Vein Occlusion
- Tissue Plasminogen Activator
-
New York, New YorkWeill Cornell Medical College/ New York Presbyterian hospital
Aug 2, 2018
Macular Edema, Central Retinal Vein Occlusion Trial in United States (Ozurdex, Avastin)
Completed
- Macular Edema
- Central Retinal Vein Occlusion
-
Toms River, New Jersey
- +3 more
Mar 5, 2018
Central Retinal Vein Occlusion Trial in Leuven (Ocriplasmin intravenously)
Completed
- Central Retinal Vein Occlusion
- Ocriplasmin intravenously
-
Leuven, Vlaams Brabant, BelgiumUZ Leuven
Jan 4, 2018
Central Retinal Vein Occlusion Trial in Worldwide (Sham injection, Ranibizumab 0.5 mg)
Completed
- Central Retinal Vein Occlusion
- Sham injection
- Ranibizumab 0.5 mg
-
Beijing, Beijing, China
- +33 more
Apr 24, 2017
Central Retinal Vein Occlusion- a Prospective Controlled Study
Completed
- Vitamin d Deficiency
- Central Retinal Vein Occlusion
-
Stockholm, SwedenSt Eriks Eye Hospital
Nov 23, 2016
Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab 0.5 mg/0.05 ml)
Completed
- Macular Edema
- Central Retinal Vein Occlusion
- Ranibizumab 0.5 mg/0.05 ml
-
Parramatta, New South Wales, Australia
- +77 more
Sep 21, 2016
Visual Impairment, Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab, Dexamethasone implant and sham
Completed
- Visual Impairment
- +2 more
- Ranibizumab
- Dexamethasone implant and sham injections
-
Augsburg, Germany
- +63 more
Sep 21, 2016
Macular Edema, Central Retinal Vein Occlusion Trial in United States (Ozurdex, Ranibizumab, Combination Ozurdex with Ranibizumab
Unknown status
- Macular Edema
- Central Retinal Vein Occlusion
- Ozurdex
- +2 more
-
Beverly Hills, California
- +4 more
Dec 10, 2015
Central Retinal Vein Occlusion, Proliferative Diabetic Retinopathy Trial in Boston (Intravitreal Aflibercept Injection)
Completed
- Central Retinal Vein Occlusion
- Proliferative Diabetic Retinopathy
- Intravitreal Aflibercept Injection
-
Boston, MassachusettsOphthalmic Consultants of Boston
May 21, 2015
Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Macular Edema Trial in United States (ranibizumab 0.5mg,
Completed
- Branch Retinal Vein Occlusion
- +2 more
- ranibizumab 0.5mg
- ranibizumab 1.0mg
-
Huntington Beach, California
- +3 more
Apr 10, 2015
Central Retinal Vein Occlusion Trial in Zerifin (Hyperbaric chamber treatment)
Unknown status
- Central Retinal Vein Occlusion
- Hyperbaric chamber treatment
-
Zerifin, IsraelAssaf Harofe MC
Mar 31, 2015
Central Retinal Vein Occlusion Trial in Creteil, Paris (ranibizumab, hemodilution)
Completed
- Central Retinal Vein Occlusion
- ranibizumab
- hemodilution
-
Creteil, France
- +1 more
Aug 12, 2014
Central Retinal Vein Occlusion Trial in Durham (fluocinolone acetonide (Retisert Implant, Bausch and Lomb))
Completed
- Central Retinal Vein Occlusion
- fluocinolone acetonide (Retisert Implant, Bausch and Lomb)
-
Durham, North CarolinaDuke Eye Center
Aug 1, 2014